Financial reports
ARS
2023 FY
Annual report to shareholders
4 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
3 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
6 Apr 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
Current reports
8-K
Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results
27 Feb 24
8-K
Privia Health Appoints Edward C. Fargis as General Counsel
29 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Entry into a Material Definitive Agreement
21 Nov 23
8-K
Privia Health Reports Third Quarter 2023 Financial Results; Announces New Market Entry in South Carolina
3 Nov 23
8-K
Privia Health Reports Second Quarter 2023 Financial Results
3 Aug 23
8-K
Privia Health Announces Changes to Board of Directors
31 Jul 23
8-K
Departure of Directors or Certain Officers
29 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
25 May 23
8-K
Other Events
10 May 23
Registration and prospectus
424B7
Prospectus with selling stockholder info
5 May 23
424B7
Prospectus with selling stockholder info
4 May 23
424B7
Prospectus with selling stockholder info
17 Nov 22
424B7
Prospectus with selling stockholder info
15 Nov 22
S-3ASR
Automatic shelf registration
15 Nov 22
424B4
Prospectus supplement with pricing info
22 Nov 21
S-1
IPO registration
16 Nov 21
DRS
Draft registration statement
28 Jul 21
424B4
Prospectus supplement with pricing info
30 Apr 21
S-8
Registration of securities for employees
29 Apr 21
Proxies
DEFA14A
Additional proxy soliciting materials
4 Apr 24
DEF 14A
Definitive proxy
4 Apr 24
PRE 14A
Preliminary proxy
21 Mar 24
DEFA14A
Additional proxy soliciting materials
10 May 23
DEFA14A
Additional proxy soliciting materials
12 Apr 23
DEFA14A
Additional proxy soliciting materials
6 Apr 23
DEF 14A
Definitive proxy
6 Apr 23
DEF 14A
Definitive proxy
11 Apr 22
Other
UPLOAD
Letter from SEC
19 Apr 23
CORRESP
Correspondence with SEC
17 Apr 23
UPLOAD
Letter from SEC
4 Apr 23
EFFECT
Notice of effectiveness
19 Nov 21
CORRESP
Correspondence with SEC
16 Nov 21
CORRESP
Correspondence with SEC
16 Nov 21
UPLOAD
Letter from SEC
29 Jul 21
EFFECT
Notice of effectiveness
29 Apr 21
CERT
Certification of approval for exchange listing
29 Apr 21
CORRESP
Correspondence with SEC
26 Apr 21
Ownership
4
David Mountcastle
4 Apr 24
144
Notice of proposed sale of securities
2 Apr 24
4
David Mountcastle
15 Mar 24
4
Parth Mehrotra
15 Mar 24
4
Edward C Fargis
15 Mar 24
4
William M Sullivan
12 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
SC 13G
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
GOLDMAN SACHS GROUP INC
13 Feb 24
SC 13G/A
FMR LLC
9 Feb 24